Miami, FL – KhemoSafe has recently developed a smart technology device that has IoT capability for hazardous waste disposal that will keep everyone safe. The intelligent unit provides a collection method that uses patented technology to prevent exposure of hazardous vapors. The Federal Agency, National Institute for Occupational Therapy and Health (NIOSH) estimates that over 8 million healthcare workers, patients and the environment are exposed to hazardous waste vapors from chemotherapy medications. KhemoSafe therefore employs patented technology to thwart exposure of vapors and using IoT technology collect relevant data to employ predictive analytics.
Studies have shown that more than 1.7 million new cancer cases are diagnosed each year in the US. Around 650,000 cancer patients receive chemotherapy every year in an outpatient oncology clinic in the US. This means that more healthcare workers are at risk of being exposed. The ‘yellow bins’ currently being used at hospitals to collect waste materials do not have an effective vapor containment system. Therefore, odorless toxic vapors are constantly emanating from these bins until they are properly removed. KhemoSafe smart technology is the only company that has patented technology to trap and contain the toxic vapors.
The unit which is motion sensored and hands-free allows healthcare workers to seamlessly dispose of hazardous waste. The intelligent unit then uploads the recorded weight to the Cloud. Thereby allowing institutions to use the data for hedging future intelligent business decisions through predictive analytics. Algorithms, using machine learning, track the data over time to reveal patterns and details that help medical facilities to manage their expenses and protect the environment. KhemoSafe then provide institutions with monthly reports on how much waste they have generated which is useful for sustainability and monitoring waste management costs.
KhemoSafe plans to use a B2B strategy by licensing the unit to healthcare institutions for a monthly or annual fee. The intelligent unit which can be utilized in any hospital, clinic, or outpatient setting that infuses chemotherapy provides cost-containment tools to afford institutions the necessary tools to remain financially competitive. It allows each facility to take complete control of how its hazardous waste is collected.
The company’s mission is to provide a safe environment for all health workers who come in contact with chemotherapy waste and cytostatic drugs. KhemoSafe plans to develop smaller systems for residential use. KhemoSafe also plans to expand its demographics to all health workers currently dealing with the global pandemic of COVID.
KhemoSafe is a start-up company that develops technology that is used to create equipment in making the collection of hazardous waste safer. Louis Soto, founder of KhemoSafe Inc, worked as a pharmacist for 26 years, experiencing first hand the dangers of hazardous waste vapor exposure. After being diagnosed with sarcoidosis due to exposure, he patented the KhemoSafe intelligent-unit is designed to ensure that no other health care worker gets sick on the job again.
Company Name: KhemoSafe
Contact Person: Louis Soto
Email: Send Email
Address:66 WEST FLAGLER STREET, SUITE# 900
State: FL, 33130
Country: United States